drug
ACETAMINOPHEN AND CODEINE PHOSPHATE
updated 3mo agoby Eon Labs Inc
community read0 votes
🐶 often sniffed alongside
top 8- drugHYDROCODONE BITARTRATE AND ACETAMINOPHEN1,124 co-mentions · 562 sources
- tagApproval1,124 co-mentions · 562 sources
- tagSmall Molecule562 co-mentions · 562 sources
- drugcodeine562 co-mentions · 562 sources
- drugPROMETHAZINE HYDROCHLORIDE AND CODEINE PHOSPHATE562 co-mentions · 562 sources
- drugPROMETH HYDROCHLORIDE,PHENYLEPHRINE HYDROCHLORIDE W/CODEINE PHOSPHATE562 co-mentions · 562 sources
- drugPROMETHAZINE HYDROCHLORIDE, PHENYLEPHRINE HYDROCHLORIDE W/CODEINE PHOSPHATE562 co-mentions · 562 sources
- companyStrides Pharma Inc63 co-mentions · 63 sources
all catalysts(0)
nothing on the calendar yet
Trials studying ACETAMINOPHEN AND CODEINE PHOSPHATE
- phase3A Study to Evaluate the Efficacy and Safety of Sacituzumab Tirumotecan (MK-2870) Maintenance Treatment Versus Standard of Care in Participants With Platinum-sensitive Recurrent Ovarian Cancer (MK-2870-022/TroFuse-022/ENGOT-ov84/GOG-3103)
- phase3A Study to Evaluate the Efficacy and Safety of Obinutuzumab in Participants With ISN/RPS 2003 Class III or IV Lupus Nephritis
- phase1A Research Study Looking Into How UBT251 Works With Birth Control Tablets and Emptying of the Stomach in Women With Excess Body Weight Not Able to Become Pregnant
- phase3A Clinical Trial of MK-1045 in People With B-cell Acute Lymphoblastic Leukemia (MK-1045-005)
- phase2A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Obinutuzumab in Adolescents With Active Class III or IV Lupus Nephritis and the Safety and PK of Obinutuzumab in Pediatric Participants
- phase3A Study of Combogesic® IV (Intravenous) in Pediatric Patients With Acute Pain
- phase1A Study to Investigate the Effect of AZD6234, AZD9550, and a Combination of AZD9550 and AZD6234 on Pharmacokinetics of Combined Oral Contraceptive Ethinyl Estradiol/Levonorgestrel in Healthy Female Participants Living With Overweight or Obesity
- phase2A Study to Evaluate Investigational Agents With or Without Pembrolizumab (MK-3475) in Participants With Advanced Esophageal Cancer Previously Exposed to Programmed Cell Death 1 Protein (PD-1)/ Programmed Cell Death Ligand 1 (PD-L1) Treatment (MK-3475-06B)
News(0)
no news has mentioned this drug yet
Data sources
last refreshed 15m ago
Found something off?
comments(0)
5-min edit window · permanent after that